Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trialJean-Marc Classe, Olivier Gléhen, Gilles Houvenaeghel et al.|The Lancet Oncology|2024Cited by 70
Results from a randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy (REASON).C. Lhommé, Mario Campone, Dominique Berton-Rigaud et al.|Journal of Clinical Oncology|2011Cited by 3
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer (CHIPOR): A Randomized, Open-Label, Phase 3 TrialJean-Marc Classe, Olivier Gléhen, Pierre Méeus et al.|Obstetrical & Gynecological Survey|2025Cited by 0